PrandiMet is a prescription medication used to treat type 2 diabetes. This selection from the eMedTV Web library features an overview of PrandiMet, including information on how it works, possible side effects, and tips on when and how to take the drug.
Some of the most common PrandiMet side effects can include headaches, nausea, and diarrhea. This eMedTV Web resource also examines some of the more serious side effects of this drug, including symptoms of lactic acidosis and allergic reactions.
This eMedTV segment discusses how PrandiMet is used for lowering blood sugar levels in adults with type 2 diabetes. This page further describes PrandiMet uses, including information on how the drug works and whether it is safe for use in children.
This page from the eMedTV Web site explains that a doctor will consider several factors before recommending a PrandiMet dosage. This page discusses these factors that may affect your dosage, and provides some general PrandiMet dosing guidelines.
Certain antibiotics, protease inhibitors, and digoxin are among the drugs that may interact with PrandiMet. This eMedTV Web article explores potential PrandiMet drug interactions, and describes the possible problems these interactions may cause.
You should not take PrandiMet if you have kidney disease or are taking certain medications. This eMedTV article discusses other important PrandiMet warnings and precautions, including information on what to tell your doctor before taking the drug.
This page from the eMedTV Web library describes possible PrandiMet overdose symptoms, such as blurry vision, seizures, and difficulty breathing. This page also discusses possible treatment options that are available.
This eMedTV page explores studies on PrandiMet (repaglinide and metformin) and pregnancy, explaining why the FDA classifies it as a pregnancy Category C medicine. This page also explains what to do if you are taking PrandiMet and pregnancy occurs.
As this eMedTV article explains, one of the components in PrandiMet (repaglinide and metformin) does pass through breast milk and could cause problems in a breastfed infant. This page further discusses the research on PrandiMet and breastfeeding.
This selection from the eMedTV site explains why there is currently no approved generic PrandiMet (repaglinide and metformin). The page also explains why it's hard to say when a generic form could become available.
This selection from the eMedTV Web site features an in-depth look at some of the possible alternatives to PrandiMet (repaglinide and metformin). This page also explains when it may be time to consider one of these PrandiMet alternatives.
HealthSavvy Sign In
|